Skip to main content

Day: February 8, 2024

AKWEL: annual turnover for 2023 up by +7.9%

        Thursday, February 8, 2024 ANNUAL TURNOVER FOR 2023 UP BY +7.9% Turnover up 9.6% at constant scope and exchange rates. Net cash of €118.3M Expected impact of restructuring on net income for 2023 AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and structural parts for electric vehicles, has recorded a consolidated turnover of €1,066.4M for 2023. Consolidated turnover (from January 1 to December 31)in €m — unaudited 2023 2022 Variation PCC variation (1)1st quarter 274.6 245.8 +11.7% +10.9%2nd quarter 271.2 242.3 +12.0% +13.6%3rd quarter 253.1 251.1 +0.8% +4.6%Nine-month total 799.0 739.2 +8.1% +9.6%Nine-month report published 781.9 739.2 +5.8% +12.3%4th quarter 267.4 249.4 +7.2% +9.4%Twelve-month...

Continue reading

Record revenue of €761 million in 2023, in line with target (> €750 M)

  PRESS RELEASE  08/02/2024 Record revenue of €761 million in 2023, in line with target (> €750 M) Solid annual growth (+7.5%) driven by all Group activities Replacement of local management and voluntarist action plan in response to the lingering difficulties in North America In Q4 2023, LACROIX revenue came to 193.8 million euros, up 1.3% on the same period in 2022. This increase was achieved entirely through organic growth, and includes a positive currency effect of €0.5 million. At constant exchange rates (CER)(1), sales growth came to +1.0% in Q4. Throughout the year, Group revenue came to €761.2 million, in line with the announced revenue target exceeding €750 million. Growth reached 7.5% in 2023 (+7.2% at CER), a solid performance achieved despite a demanding basis for comparison: fiscal 2022, already up 8.6% on a like-for-like...

Continue reading

Snail, Inc. Participates in Fireside Chat Hosted by IPO Edge

CULVER CITY, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) — Snail, Inc. (Nasdaq: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital entertainment, today announced that Jim Tsai, Chief Executive Officer of Snail, participated in a fireside chat hosted by IPO Edge as part of the IPO Summit at the New York Stock Exchange on Thursday, February 8th 2024. The webcast of the event can be found on the IPO Edge website, found here and on the Snail, Inc. investor relations website, found here. About Snail, Inc. – https://www.snailgamesusa.com/ Snail is a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs...

Continue reading

Icelandic Salmon – Invitation to presentation for the fourth quarter 2023 results Icelandic Salmon AS

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Bíldudalur, 8th of February 2024. Icelandic Salmon will be presenting results for the fourth quarter of 2023 on Thursday the 15th of February 2024. The presentation will be held in English via webcast, please copy and paste the following link into your browser: arnarlax.webcast.is The company’s CEO Bjørn Hembre and CFO Jónas Heiðar Birgisson will be presenting the company’s results at 8:00 Icelandic time (09:00 CEST). There will be a Q&A session after the presentations so you can send in questions during the presentation to questions@arnarlax.is  A recording of the presentation will be made available on the company’s website. After the presentation there is an opportunity to book one on one meeting either...

Continue reading

Medical Device Contract Manufacturing Market to Surpass 172.48 Billion by 2030 Drives Due to Rising Adoption of Immunotherapy Drugs

SkyQuest projects that the medical device contract manufacturing market will attain a value of USD 172.48 billion by 2030, with a CAGR of 11.30% over the forecast period (2023-2030). The expansion of this medical device contract manufacturing market can be primarily attributed to a rising demand for effective treatments targeting specific diseases, a burgeoning interest in biosimilars and monoclonal antibodies, and a significant upsurge in the adoption of immunotherapy drugs as compared to conventional treatment approaches. Westford, USA, Feb. 08, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the medical device contract manufacturing market is experiencing significant momentum due to the rising elderly population, particularly in developed nations, and increased healthcare expenditure in these regions. This demographic shift drives...

Continue reading

Inside information: Varma to co-invest alongside OP Finland Infrastructure in Aspo’s subsidiary ESL Shipping

Aspo PlcInside informationFebruary 8, 2024 at 18:20 Inside information: Varma to co-invest alongside OP Finland Infrastructure in Aspo’s subsidiary ESL Shipping Varma Mutual Pension Insurance Company has agreed to co-invest EUR 15 million alongside OP Finland Infrastructure LP in Aspo’s subsidiary ESL Shipping. As a result, the combined investment into ESL Shipping managed by OP Finland Infrastructure LP rises to total of EUR 45 million at the closing of the transaction. The co-investment by Varma is made with the same valuation and terms as agreed between Aspo and OP Finland Infrastructure in their 8 November 2023 announced EUR 30 million investment in ESL Shipping. Competition authority approvals and change of control approvals from financial institutions have been received and the closing of OP Finland Infrastructure LP’s investment...

Continue reading

Breyting á fjárhagsdagatali 2024

Ísfélag hf. tilkynnir hér með um breytingu á Fjárhagsdagatali sem birt var þann 08.12.2023. Breytingin lýtur að birtingu ársuppgjörs 2023 sem skv. ákvörðun stjórnar færist fram um tvo daga.         Birting ársuppgjörs 2023 27. mars 2024    Aðalfundur 17. apríl 2024    Birting uppgjörs Q1 2024 31. maí 2024    Birting uppgjörs Q2 2024 30. ágúst 2024    Birting uppgjörs Q3 2024 29. nóvember 2024              Vinsamlegast athugið að dagsetningarnar eru birtar með fyrirvara um breytingar.

Continue reading

Green Hydrogen Systems adjusts its revenue guidance for 2024

Company announcement 04/2024 Green Hydrogen Systems adjusts its revenue guidance for 2024 Kolding, Denmark, 8 February 2024 – Green Hydrogen Systems A/S adjusts its revenue guidance for 2024 as published in Company Announcement No. 1/2024 of 23 January 2024. The adjustment is reflected in a new expectation for revenue for the full year 2024 in the range of DKK 125 to 165 million (previously: DKK 110 to 150 million). The adjusted revenue range has been made in recognition of the recently signed order as stated in Company Announcement No. 03/2024 of 8 February 2024 covering 9 units of the HyProvide® A-series electrolyser for a total capacity of 8.1MW. Updated guidance for 2024 is summarised as follows: o        Revenue, DKK 125 to 165 million (previously: DKK 110 to 150 million) o        EBITDA, DKK -260 to -220 million (maintained) o        CAPEX,...

Continue reading

Green Hydrogen Systems signs new order for 8.1 MW electrolyser capacity

Company announcement 03/2024 Green Hydrogen Systems signs order for 8.1 MW electrolyser capacity Kolding, Denmark, 8 February 2024 – Green Hydrogen Systems A/S announces an order covering 9 units of the HyProvide® A-series electrolyser for a total capacity of 8.1MW. The units are scheduled for delivery in 2024 and 2025. The electrolyser order is signed with one of the Company’s existing customers in the UK, specialising in renewable off-grid energy generation. “We are excited to announce this new order. It reaffirms the competitive position of our standardised, modular, pressurised alkaline electrolysers,” says Green Hydrogen Systems’ CCO, Søren Rydbirk. Green Hydrogen Systems will be responsible for delivering the electrolyser units as well as on-site maintenance, remote monitoring and operational support as part of a multi-year service...

Continue reading

Activated Alumina Market to Surpass 256.92 Million by 2030 Drives Due to Rising Demand for Clean and Potable Water Sources

SkyQuest projects that the activated alumina market will attain a value of USD 256.92 million by 2030, with a CAGR of 5.8% over the forecast period (2023-2030). Several crucial factors predominantly steer the market for this particular technology in the activated alumina market. There is a notable surge in the demand for clean and potable water sources, driven by growing concerns over water pollution and scarcity. Westford, USA, Feb. 08, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the demand for activated alumina market within the water treatment industry has witnessed a steady rise, primarily propelled by the increasing requirement for clean and potable water sources. Activated alumina is a versatile solution with its remarkable capacity to eliminate contaminants and impurities from water efficiently. Get sample copy of this...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.